Dr Salman Razvi
Dr Rosie Dew
Dr Scott Wilkes
| Cardiovascular and bone health outcomes in older people with subclinical hypothyroidism treated with levothyroxine: a systematic review and meta-analysis | 2024 |
|
Dr Salman Razvi
Dr Yaasir Mamoojee
| Clinical Impact of New Reference Intervals for the Roche Prolactin II Immunoassay | 2024 |
|
Dr Salman Razvi
| Importance of right communication with healthcare providers and patients about the new levothyroxine formulation: an expert opinion from Asia Pacific Thyroid Advisory Board | 2024 |
|
Dr Salman Razvi
| Should we reconsider blocking the thyroid for 123I-Ioflupane studies in elderly patients: quantifying radiation dose to the unblocked thyroid and implications for clinical practice | 2024 |
|
Dr Salman Razvi
| Thyroid function reference ranges in the diagnosis of thyroid dysfunction in adults | 2024 |
|
Dr Salman Razvi
Dr Rosie Dew
Dr Scott Wilkes
| Assessing the cardiovascular effects of levothyroxine use in an ageing United Kingdom population (ACEL-UK) protocol: a cohort and target trial emulation study | 2023 |
|
Dr Salman Razvi
| Cardiac Safety and Efficacy of Combination Levothyroxine and L-Triiodothyronine in Patients with Athyreotic Hypothyroidism: Reassuring Initial Data but More Is Needed | 2023 |
|
Dr Salman Razvi
| Editorial: Treatment of Subclinical Thyroid Dysfunction in Patients with Comorbidities | 2023 |
|
Dr Laura Lane
Professor Timothy Cheetham
Dr Salman Razvi
Kathleen Allinson
Professor Simon Pearce
et al. | Expansion of the immature B lymphocyte compartment in Graves' disease. | 2023 |
|
Dr Petros Perros
Professor Simon Pearce
Dr Salman Razvi
Dr Alison Dickinson
| Inter-observer Variability of Clinical Activity Score: Assessments in Patients With Thyroid Eye Disease | 2023 |
|
Sophie Howarth
Kathleen Allinson
Dr Salman Razvi
Dr Anna Mitchell
Professor Simon Pearce
et al. | Replication of association at the LPP and UBASH3A loci in a UK autoimmune Addison's disease cohort. | 2023 |
|
Dr Salman Razvi
| Subclinical hypothyroidism, outcomes and management guidelines: a narrative review and update of recent literature. | 2023 |
|
Dr Salman Razvi
| The GLP-1 receptor agonist Exenatide reduces serum TSH by its effect on body weight in people with Type 2 Diabetes | 2023 |
|
Dr Salman Razvi
| The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis | 2023 |
|
Dr Salman Razvi
| Treating subclinical hypothyroidism in individuals with or without mental health problems –A Delphi based expert consensus study in two countries | 2023 |
|
Dr Salman Razvi
Dr Avais Jabbar
Clare Addison
| Variation in the reference range limits of thyroid function tests and association with the prevalence of levothyroxine treatment | 2023 |
|
Emily Hunter
Professor Anthony De Soyza
Dr Rachel Agbeko
Dr Ken Baker
Dr Quentin Campbell Hewson
et al. | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | 2022 |
|
Dr Ryan Kenny
Professor John Dark
Dr Arjola Bano
Dr Salman Razvi
| Efficacy and safety of Triiodothyronine (T3) treatment in Cardiac Surgery or Cardiovascular Diseases – a Systematic Review and Meta-analysis of Randomized Controlled Trials | 2022 |
|
Professor David Kennedy
Dr Salman Razvi
| Frequency, determinants and costs of thyroid function testing in a laboratory serving a large population | 2022 |
|
Dr Salman Razvi
| Getting the levothyroxine (LT4) dose right for adults with hypothyroidism: opportunities and challenges in the use of modern LT4 preparations | 2022 |
|
Dr Salman Razvi
| Hypothyroidism | 2022 |
|
Dr Petros Perros
Dr Bijayeswar Vaidya
Dr Salman Razvi
Dr Asgar Madathil
Emeritus Professor Stephen Jarvis
et al. | Post-radioiodine Graves' management: the PRAGMA study | 2022 |
|
Dr Salman Razvi
| Subclinical thyroid dysfunction and incident diabetes: a systematic review and an individual participant data analysis of prospective cohort studies | 2022 |
|
Nicholas Vennart
Dr Jolanta Weaver
Dr Salman Razvi
| The prevalence and significance of non-uniform thyroid radio-isotope uptake in patients with Graves’ disease | 2022 |
|
Dr Salman Razvi
Dr Avais Jabbar
Professor Azfar Zaman
| Triiodothyronine (T3), inflammation and mortality risk in patients with acute myocardial infarction | 2022 |
|
Shaun Hiu
Professor Dawn Teare
Dr Salman Razvi
| A Global Country Level Analysis of The Relationship between Obesity and COVID-19 Cases and Mortality | 2021 |
|
Dr Salman Razvi
| Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis | 2021 |
|
Dr Salman Razvi
| Does Clinical and Biochemical Thyroid Dysfunction Impact on Endometrial Cancer Survival Outcomes? A Prospective Database Study | 2021 |
|
Dr Kerri Devine
Dr Salman Razvi
Dr Richard Quinton
Dr Nicola Leech
| Iatrogenic hypoglycaemia following glucose-insulin infusions for the treatment of hyperkalaemia | 2021 |
|
Dr Salman Razvi
Dr Bronia Arnott
Shaun Hiu
Dr Nicki O'Brien
Professor Simon Pearce
et al. | Multinational Survey of Treatment Practices of Clinicians Managing Subclinical Hypothyroidism in Older People in 2019 | 2021 |
|
Dr Avais Jabbar
Lorna Ingoe
Dr Shahid Junejo
Dr David Austin
Professor Azfar Zaman
et al. | Prevalence, Predictors and Outcomes of Thyroid Dysfunction in patients with Acute Myocardial Infarction: the ThyrAMI-1 Study | 2021 |
|
Dr Salman Razvi
| Treatment of subclinical hypothyroidism: assessing when treatment is likely to be beneficial | 2021 |
|
Dr Salman Razvi
Vicky Ryan
Professor Simon Pearce
Dr Scott Wilkes
| Age-related serum Thyroid Stimulating Hormone Reference range in Older Patients treated with Levothyroxine: a Randomized Controlled Feasibility Trial (SORTED 1) | 2020 |
|
Dr Avais Jabbar
Lorna Ingoe
Dr Shahid Junejo
Dr Peter Carey
Dr Honey Thomas
et al. | Effect of levothyroxine on left ventricular ejection fraction in patients with subclinical hypothyroidism and acute myocardial infarction: a randomized clinical trial | 2020 |
|
Dr Salman Razvi
| Exposure of hospital healthcare workers to the novel coronavirus (SARS-CoV-2) | 2020 |
|
Dr Salman Razvi
| Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review | 2020 |
|
Dr Salman Razvi
Dr Akheel Syed
| Obesity: A critical risk factor in the COVID‐19 pandemic | 2020 |
|
Dr Salman Razvi
Dr Avais Jabbar
Dr Arjola Bano
Lorna Ingoe
Dr Peter Carey
et al. | Sample Timing, Diagnosis of Subclinical Thyroid Dysfunction and Mortality in Acute Myocardial Infarction: ThyrAMI1 Study | 2020 |
|
Dr Salman Razvi
| Thyroid function and the risk of fibrosis of the liver, heart and lung in humans: A systematic review and meta-analysis | 2020 |
|
Professor Simon Pearce
Dr Petros Perros
Dr Salman Razvi
| Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study | 2019 |
|
Dr Salman Razvi
| Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction | 2019 |
|
Dr Salman Razvi
| Hypothyroidism in the older population | 2019 |
|
Dr Salman Razvi
| Liothyronine cost and prescriptions in England | 2019 |
|
Dr Salman Razvi
| Novel uses of thyroid hormones in cardiovascular conditions | 2019 |
|
Dr Salman Razvi
| Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers | 2019 |
|
Dr Salman Razvi
| Therapeutic challenges in the application of serum thyroid stimulating hormone testing in the management of patients with hypothyroidism on replacement thyroid hormone therapy: a review | 2019 |
|
Dr Salman Razvi
Professor Simon Pearce
| Thyroid Hormone Therapy for Subclinical Hypothyroidism [Comment & Response] | 2019 |
|
Dr Arjola Bano
Dr Earn Gan
Dr Jolanta Weaver
Dr Salman Razvi
| Age may influence the impact of TRAbs on thyroid function and relapse-risk in patients with Graves’ disease | 2018 |
|
Dr Laura Lane
Kathleen Allinson
Lorna Ingoe
Dr Salman Razvi
Professor Timothy Cheetham
et al. | Analysis of BAFF gene polymorphisms in UK Graves' disease patients | 2018 |
|
Professor Simon Pearce
Dr Salman Razvi
| Attitudes and perceptions of health professionals towards management of hypothyroidism in general practice: a qualitative interview study. | 2018 |
|
Lorna Ingoe
Professor Simon Pearce
Professor Tim Rapley
Dr Salman Razvi
Dr Scott Wilkes
et al. | Older patients' experience of primary hypothyroidism: A qualitative study | 2018 |
|
Dr Salman Razvi
Dr Avais Jabbar
Professor Azfar Zaman
| Thyroid Hormones and Cardiovascular Function and Diseases | 2018 |
|
Dr Salman Razvi
| Trends, Determinants and Associations of Treated Hypothyroidism in the United Kingdom, 2005-2014 | 2018 |
|
Dr Salman Razvi
Professor Simon Pearce
Dr Scott Wilkes
| Clinical, behavioural and pharmacogenomic factors influencing the response to levothyroxine therapy in patients with primary hypothyroidism-protocol for a systematic review | 2017 |
|
Professor Simon Pearce
Dr Salman Razvi
Dr Scott Wilkes
| Patients' attitudes and perceptions towards treatment of hypothyroidism in general practice: an in-depth qualitative interview study | 2017 |
|
Lorna Ingoe
Arvind Rajagopal
Dr Salman Razvi
| Prevalence of treated hypothyroidism in the community: Analysis from general practices in North-East England with implications for the United Kingdom | 2017 |
|
Dr Earn Gan
Dr Salman Razvi
| The role of local thyroid hormone perturbation in hippocampal sclerosis dementia - commentary on a multi-modality study | 2017 |
|
Dr Avais Jabbar
Professor Simon Pearce
Professor Azfar Zaman
Dr Salman Razvi
| Thyroid hormones and cardiovascular disease | 2017 |
|
Dr Fahad Ahmed
Rachel Rider
Dr Michael Glanville
Dr Salman Razvi
Dr Jolanta Weaver
et al. | Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study | 2016 |
|
Professor Thomas Hill
Dr Antoneta Granic
Dr Karen Davies
Dr Joanna Collerton
Dr Carmen Martin-Ruiz
et al. | Serum 25-hydroxyvitamin D concentration and its determinants in the very old: The Newcastle 85+ study | 2016 |
|
Professor Simon Pearce
Dr Salman Razvi
Mohammad Yadegarfar
Dr Carmen Martin-Ruiz
Dr Andrew Kingston
et al. | Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+Study | 2016 |
|
Dr Salman Razvi
Lorna Ingoe
Vicky Ryan
Professor Simon Pearce
Dr Scott Wilkes
et al. | Study of Optimal Replacement of Thyroxine in the Elderly (SORTED) - results from the feasibility randomised controlled trial | 2016 |
|
Dr Sviatlana Zhyzhneuskaya
Dr Jolanta Weaver
Dr Salman Razvi
| The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds | 2016 |
|
Dr Asgar Madathil
Dr Kieren Hollingsworth
Professor Andrew Blamire
Dr Salman Razvi
Emerita Professor Julia Newton
et al. | Levothyroxine Improves Abnormal Cardiac Bioenergetics in Subclinical Hypothyroidism: A Cardiac Magnetic Resonance Spectroscopic Study | 2015 |
|
Wendy den Elzen
Dr Salman Razvi
| Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis | 2015 |
|
Wendy den Elzen
Dr Patricia Kearney
Dr Salman Razvi
| Thyroid Function Within the Normal Range and Risk of Coronary Heart Disease: An Individual Participant Data Analysis of 14 Cohorts | 2015 |
|
Dr Avais Jabbar
Professor Simon Pearce
Professor Azfar Zaman
Dr Salman Razvi
| Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial | 2015 |
|
Dr Girish Viswanathan
Dr Karthik Balasubramaniam
Emerita Professor Sally Marshall
Professor Azfar Zaman
Dr Salman Razvi
et al. | Blood Thrombogenicity is Independently Associated with Serum TSH Levels in Post-Non-ST Elevation Acute Coronary Syndrome | 2014 |
|
Wendy den Elzen
Dr Salman Razvi
| Thyroid Antibody Status, Subclinical Hypothyroidism, and the Risk of Coronary Heart Disease: An Individual Participant Data Analysis | 2014 |
|
Dr Avais Jabbar
Dr Salman Razvi
| Thyroid disease and vascular risk | 2014 |
|
Professor Simon Pearce
Dr Salman Razvi
| 2013 ETA Guideline: Management of Subclinical Hypothyroidism | 2013 |
|
Dr Karthik Balasubramaniam
Dr Girish Viswanathan
Emerita Professor Sally Marshall
Dr Salman Razvi
Professor Azfar Zaman
et al. | Higher Thrombus Burden in Patients with Subclinical Hypothyroidism after Non ST Elevation Acute Coronary Syndrome | 2013 |
|
Dr Scott Wilkes
Professor Simon Pearce
Vicky Ryan
Dr Tim Rapley
Lorna Ingoe
et al. | Study of Optimal Replacement of Thyroxine in the ElDerly (SORTED): protocol for a mixed methods feasibility study to assess the clinical utility of lower dose thyroxine in elderly hypothyroid patients: study protocol for a randomized controlled trial | 2013 |
|
Dr Salman Razvi
Dr Jolanta Weaver
Dr Tim Butler
Professor Simon Pearce
| Levothyroxine Treatment of Subclinical Hypothyroidism, Fatal and Nonfatal Cardiovascular Events, and Mortality | 2012 |
|
Dr Salman Razvi
Professor Simon Pearce
| Subclinical Hypothyroidism and Cardiovascular Disease Reply | 2012 |
|
Dr Shaikh Abdul Shakoor
Dr Ali Aldibbiat
Lorna Ingoe
Dr Susan Campbell
Dr Latika Sibal
et al. | Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement Therapy | 2010 |
|
Dr Salman Razvi
Dr Jolanta Weaver
Professor Simon Pearce
| Subclinical thyroid disorders: significance and clinical impact | 2010 |
|
Dr Salman Razvi
Dr Jolanta Weaver
Professor Simon Pearce
| The Incidence of Ischemic Heart Disease and Mortality in People with Subclinical Hypothyroidism: Reanalysis of the Whickham Survey Cohort | 2010 |
|
Dr Latika Sibal
Dr Ali Aldibbiat
Dr Sharad Agarwal
Crispian Oates
Dr Salman Razvi
et al. | Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria | 2009 |
|
Dr Salman Razvi
Dr Jolanta Weaver
| Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: The ThyDQoL and ThySRQ | 2008 |
|
Dr Salman Razvi
Dr Jolanta Weaver
Professor Simon Pearce
| The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: A metaanalysis | 2008 |
|
Dr Salman Razvi
David Perrow
| A 52-year-old female with a hoarse voice and tingling in the hand | 2007 |
|
Dr Salman Razvi
Professor Simon Pearce
| Do antithyroid drugs influence outcome after radioiodine therapy for hyperthyroidism? | 2007 |
|
Dr Latika Sibal
Dr Ali Aldibbiat
Dr Jolanta Weaver
Dr Salman Razvi
Crispian Oates
et al. | Endothelial dysfunction and circulating endothelial progenitor cells in young people with type 1 diabetes | 2007 |
|
Dr Latika Sibal
Dr Ali Aldibbiat
Dr Sharad Agarwal
Dr Jolanta Weaver
Dr Salman Razvi
et al. | Endothelial dysfunction, carotid intima media thickness and circulating endothelial progenitor cells in young people with Type 1 diabetes | 2007 |
|
Dr Salman Razvi
Lorna Ingoe
Crispian Oates
Dr Jolanta Weaver
| The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: Randomized, crossover trial | 2007 |
|
Dr Ibrahim Ibrahim
Dr Ee Lim
Dr Salman Razvi
Professor Simon Pearce
Dr Stuart Bennett
et al. | Langerhans cell histiocytosis: management dilemma for the adult endocrinologist | 2006 |
|
Dr Salman Razvi
Dr Simon Ashwell
Dr Richard Quinton
| Prolactinomas: all in the family? | 2006 |
|
Dr Salman Razvi
Dr Jolanta Weaver
| Psychometric evaluation of a new questionnaire measuring treatment satisfaction in hypothyroidism: The ThyTSQ | 2006 |
|
Dr Salman Razvi
Dr Bijayeswar Vaidya
Dr Petros Perros
Professor Simon Pearce
| What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves' disease | 2006 |
|
Dr Jolanta Weaver
Dr Salman Razvi
| Dose of anti-thyroid drugs can effect remission in grave's disease | 2005 |
|
Dr Salman Razvi
Lorna Ingoe
Dr Jolanta Weaver
| Health status in patients with sub-clinical hypothyroidism | 2005 |
|
Dr Salman Razvi
Dr Jolanta Weaver
| Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: A systematic qualitative review | 2005 |
|
Dr Jolanta Weaver
Dr Salman Razvi
| The detrimental effect of anti-thyroid drugs on the outcome of radioiodine therapy is not directly due to decreased radioiodine uptake [2] (multiple letters) | 2005 |
|
Dr Salman Razvi
Dr Jolanta Weaver
| Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism | 2004 |
|
Dr Salman Razvi
Dr Elizabeth McIntyre
Dr S Wahid
Dr Jolanta Weaver
| Low failure rate of fixed administered activity of 400 MBq 131I with pre-treatment with carbimazole for thyrotoxicosis: The Gateshead protocol | 2004 |
|
Dr Salman Razvi
Dr Elizabeth McIntyre
Dr Jolanta Weaver
| Low failure rate of fixed dose 400 MBq131I with pre-treatment with Carbimazole for thyrotoxicosis; The Gateshead protocol | 2004 |
|
Dr Salman Razvi
Dr Jolanta Weaver
| Subclinical hypothyroidism and cardiovascular risk | 2004 |
|
Dr Jolanta Weaver
Dr Salman Razvi
| Withdrawal of anti-thyroid drugs (ATD) in a retrospective analysis of patients treated for Graves’s thyrotoxicosis. | 2004 |
|
